Neuroendocrine bronchial and thymic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 (English)In: Annals of Oncology, ISSN 0923-7534, E-ISSN 1569-8041, Vol. 21, no Suppl 5, v220-v222 p.Article in journal (Refereed) Published
The annual incidence of lung neuroendocrine tumour has been reported to be 1.35/100 000/year and the overall age adjusted incidence for thymic carcinoid 0.02/100 000/year. Of all neuroendocrine tumours, ∼25% are located in the respiratory tract. Both bronchial and thymic carcinoids may be part of multiple endocrine neoplasia type 1 syndrome (MEN-I) (5%–15%). The median age at diagnosis for lung neuroendocrine tumours is 64 years and for thymic tumours 59 years.
Place, publisher, year, edition, pages
2010. Vol. 21, no Suppl 5, v220-v222 p.
Cancer and Oncology
IdentifiersURN: urn:nbn:se:uu:diva-129542DOI: 10.1093/annonc/mdq191ISI: 000278968900045PubMedID: 20555085OAI: oai:DiVA.org:uu-129542DiVA: diva2:344244